Lario Therapeutics
lariotx.com
Actively hiring
Artificial Intelligence
Neurology & CNS Therapeutics
Medical AI
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
Epidarex Capital
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2021
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Epidarex Capital Similar startupsby what they do, their industry and backers
Restoring energy. Next-generation disease-modifying medicines for ALS and Parkinson's.
Damona Pharmaceuticals is developing precision neuromedicines to reverse cognitive deficits associated with brain disorders.associated with…
Developing transformative medicines for neurological and mental health disorders.
Transforming the field of immune tolerance with a novel antigen-specific and targeted nanoparticle technology. Topas Therapeutics is…
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly…
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…
Overview
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Edinburgh
United Kingdom
Regional office
CONTACT US
10-50 est. staff
137A George Street,, Edinburgh, UK EH2 4JY